Moshkevich Solomon

Moshkevich Solomon, president of clinical diagnostics at Natera, has filed 95 Form 4 transactions, all in the single ticker NTRA. The pattern is one-directional: 25 open-market sales in the most recent period and zero purchases. Across all filings, the total sell value is $25,216,832.69, with no buy value and no acquired value. Every transaction code is S, an open-market sale. The recent trades cluster at the start of each month. On September 2, 2026, Solomon sold NTRA shares worth $4,955,713.04, the largest single transaction in the recent set. The prior day, September 1, saw three separate sales totaling $962,193.72. August 3 had seven sales ranging from $34,393.14 to $330,181.25, summing to roughly $905,626.90. July 28 and 27 produced sales of $305,900.88 and $263,095.71. July 1 brought three sales worth $818,710.50 combined. June 1 had four sales totaling $655,294.81, and May 26 and May 1 added $335,091.35 and $392,699.66 respectively. The monthly cadence is consistent: sales land on or near the first trading day of each month from May through September 2026. The dollar values vary widely, from a low of $26,718.50 to the September 2 peak above $4.9 million. There is no compensating buy activity in the record. Solomon's filings show a sustained sell bias across the entire period, with the largest disposition occurring most recently.